Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 23 of about 9 companies and 14 funds for Gene Douglas�
Company Exchange Symbol Last price Quote change Market cap
Qiagen NV NASDAQ QGEN 24.79 -0.12 (-0.48%) 5.97B
Assay technologies are then used to provide results for analysis, such as the DNA of a virus or a mutation of a gene contained in a cancer cell, ...
GenVec Inc NASDAQ GNVC 3.30 +0.06 (1.85%) 55.11M
GenVec, Inc. (GenVec) is a biopharmaceutical company, engaged in the creation of therapeutics and vaccines. The Company works with companies and ...
Precision Drilling Corp (USA) NYSE PDS 6.09 +0.04 (0.66%) 1.78B
Precision Drilling Corporation (Precision) is an oilfield services company. Precision provides contract drilling, well servicing and support services to ...
Executive:
Gene C. Stahl
Precision Drilling Corporation TSE PD 7.54 -0.02 (-0.26%) 2.21B
Precision Drilling Corporation (Precision) is an oilfield services company. Precision provides contract drilling, well servicing and support services to ...
Executive:
Gene C. Stahl
Applied Micro Circuits Corporation NASDAQ AMCC 5.66 +0.14 (2.54%) 435.70M
The Company's products include the X-Gene ARM 64 bit Server on a Chip solution, along with the X-Weave family of connectivity products, for cloud/hyperscale ...
Qiagen NV ETR QIA 22.14 0.00 (0.00%) 5.36B
Assay technologies are then used to provide results for analysis, such as the DNA of a virus or a mutation of a gene contained in a cancer cell, ...
Qiagen NV FRA QIA 22.32 -0.01 (-0.04%) 5.36B
Assay technologies are then used to provide results for analysis, such as the DNA of a virus or a mutation of a gene contained in a cancer cell, ...
Assurant, Inc. NYSE AIZ 60.55 -0.82 (-1.34%) 4.22B
Assurant, Inc. (Assurant) is a provider of specialized insurance products and related services in North America and select worldwide markets.
Executive:
Gene E. Mergelmeyer
Critical Outcome Technologies Inc. CVE COT 0.250 +0.010 (4.17%) 29.38M
Critical Outcome Technologies Inc. (COTI) is a Canada-based biotechnology company focused on applying its computer-based technology, CHEMSAS, to identify, ...
Executive:
Gene Kelly
Mutual Fund Symbol Nav Nav change
American Beacon Small Cap Value Fund Class Institutional AVFIX 25.37 -0.13 (-0.51%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Investor Class AVPAX 24.57 -0.13 (-0.53%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Investor Class AAEPX 10.30 -0.11 (-1.06%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class AMR AAMRX 10.60 -0.12 (-1.12%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Advisor Class AASSX 24.32 -0.13 (-0.53%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class A AEMAX 10.31 -0.11 (-1.06%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class Y ABSYX 25.09 -0.13 (-0.52%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class A ABSAX 24.25 -0.13 (-0.53%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class AMR AASVX 25.27 -0.12 (-0.47%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class Institutional AEMFX 10.51 -0.11 (-1.04%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class Y ACEYX 10.57 -0.11 (-1.03%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund C Class AEMCX 10.19 -0.11 (-1.07%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class R ASCVX 23.82 -0.12 (-0.50%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund C Class ASVCX 23.65 -0.12 (-0.50%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.